Ads
related to: Stelara- About STELARA®
Information on Getting Started
Learn More About STELARA® Today
- Cost Support Information
Learn About Cost Support Options
View Support Program Info.
- Save on STELARA®
Eligible Patients pay $5 copay/dose
2020 additional requirements apply
- Patient Resources
Information About Injecting
Cost Support and More
- About STELARA®
Search results
Earnings call: Alvotech eyes robust growth with biosimilar launches By Investing.com
Investing.com· 7 days agoFDA inspections, paving the way for the entry of its products into the world's largest...
Analysis | This state isn’t waiting for Biden to negotiate drug prices
Washington Post· 2 days agoToday’s edition: President Biden and Vice President Harris are traveling to North Carolina to tout...
Update on biosimilars in Canada – March 2024 | JD Supra
JD Supra· 1 day agoIn this article, we provide a further update on developments regarding biosimilars in Canada (approvals, pending submissions, litigation, regulatory, and market access) since our March 2023 ...
Enbrel drugmaker sues over Colorado’s potential price cap, says prescription drug board is...
Greeley Tribune· 1 day agoA drugmaker whose product could be the first subjected to a price cap in Colorado is suing to throw...
Biden said Medicare drug price negotiations cut the deficit by $160B. That’s years away
Boston Herald· 2 days agoPresident Joe Biden has been making his case for reelection to voters by telling them he is good for...
Charlottesville: Virginians urge Youngkin to sign bill in support of drug affordability board
Augusta Free Press· 7 days agoThe mobile billboard in support of a Prescription Drug Affordability Board continued its tour of...
Alvotech (NYSE:ALVO) Given New $20.00 Price Target at Barclays
ETF DAILY NEWS· 5 days agoAlvotech (NYSE:ALVO – Free Report) had its price objective upped by Barclays from $17.00 to $20.00 in a research report report published on Friday, Benzinga reports. They currently have an overweight ...
Ads
related to: Stelara